FindTrial
Sign In

A clinical trial to compare the rise in hemoglobin and serum ferritin levels after giving either intravenous iron sucrose or oral ferrous ascorbate to anemic pregnant women.

Iron Deficiency Anemia in Pregnancy:Intravenous Versus Oral Route

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2010/091/001290
Enrollment
200
Registered
2010-10-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Iron Deficiency Anemia in pregnancy.

Interventions

Intervention1: intravenous iron sucrose: Total dose required=2.4xweightxhemoglobindeficit+500.(target hemoglobin =12gm/dl) Control Intervention1: oral ferrous ascorbate: 200 mg daily

Sponsors

Dr Deeba Shafi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women between 28 and 37 weeks of gestation. hemoglobin between 6 and 10gm% iron deficiency anemia.

Exclusion criteria

Exclusion criteria: Anemia from cause other than iron deficiency. Multiple pregnancy History of previous blood transfusion. History of hematological disease. Risk of preterm labour. Intolerance to iron derivatives. Recent administration of iron. Current usage of iron supplements

Design outcomes

Primary

MeasureTime frame
increase in hemoglobin in g/dlTimepoint: increase in hemoglobin at 2weeks,4 weeks and at 6 weeks.—

Secondary

MeasureTime frame
Increse in serum ferritin levels from baseline.Timepoint: increase at 2 weeks, 4weeks an at 6 weeks.—

Countries

India

Contacts

Public Contactdr deeba shafi
deebashafi@gmail.com022 26591247,09820045199

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026